Clinical Assays Operations Manager
Do you want to work in a company that is empowering the globalpopulation with a healthier future through the delivery of innovativeand affordable medical solutions? Clover Biopharmaceuticals’ vision isto deliver next-generation solutions to empower the global populationwith a healthier future. Our mission is to leverage our cutting-edgeTrimer-Tag™ technology platform and fully integrated manufacturingcapabilities for the discovery, development, and delivery of innovativeand affordable medical solutions.
Key Responsibilities:
Support global objectives of Clinical Development, Assay strategyLead(s) and VP of Clinical Operations in every aspect of clinical sampletesting.
Review clinical trial lab manuals and preparing Serology testing plansto meet the endpoint objectives of clinical trials.
Partner with clinical operations manager and study medical director toimplement the Serology testing plan for the clinical endpoints instudies, in compliance with GCP-ICH guidelines.
Draft and execute contracts, work orders with bio-analytical vendorlabs, based on Serology testing plans. • Oversee and manage Serologybudget of clinical sample testing for all studies of the program.
Responsible for sample management for the clinical study withoversight of shipment conditions and timing from the clinical site tothe central laboratory, delivery of samples to the bio-analyticalvendor, testing, reconciliation, data transfer, and final long-termstorage or further use of clinical samples.
Manage and perform periodic quality check of the trial master file(TMF) documents owned by Serology in accordance with regulatoryrequirements and Quality management system.
Requirements:
MS with a minimum of 3 years or BS with a minimum of 5 yearsdemonstrated excellence in project/program management work in thepharmaceutical environment and/or work with vaccines. Practicallaboratory experience desirable
Experience and demonstrated success in vendor management, includingcoordination and tracking of timelines and payments
Have exceptional communication skills with ability to communicateclearly with global operating matrix team
Fluent in spoken and written English.
Good knowledge and understanding of GMP, ICH-GCP and GCLP guidelinesfor clinical development of vaccines
Experience in working with document management system and electronictrial master file (e-TMF) systems used for archiving clinical studydocuments
For more information, please visit our website: ********
三叶草生物成立于2007年,是一家处于临床试验阶段的全球生物制药公司,致力于开发新型疫苗和生物疗法,以应对传染性疾病、癌症和自身免疫性疾病。我们自GenHunter授权引进Trimer-Tag?技术平台,一个用于新型疫苗和生物疗法的产品开发平台。我们的研发管线包括六种Trimer-Tag? 亚单位候选疫苗、两种 Trimer-Tag?肿瘤治疗候选产品以及三种 Fc融合蛋白候选产品。应用Trimer-Tag?技术平台,我们已成为新冠疫苗开发企业并研制了“SCB-2019(CpG1018/铝佐剂)”,以应对由SARS-CoV-2(新冠病毒)引起的新冠大流行。基于积极的“SPECTRA”试验数据,三叶草生物有望成为全球范围内通过COVAX机制率先实现重组蛋白新冠疫苗商业化上市的企业之一。
Trimer-Tag?(蛋白质三聚体化)技术平台可以使任意一个目的蛋白三聚体化*,从而可靶向那些天然依赖蛋白质三聚体化功能的疾病生物学靶点,包括数十种包膜RNA 病毒,如冠状病毒、狂犬病毒、呼吸道合胞病毒(RSV)、流感病毒、人类免疫缺陷病毒(HIV)及埃博拉病毒等,以及肿瘤坏死因子(TNF)超家族(TNFSF)的细胞因子。这些肿瘤坏死因子(TNF)超家族(TNFSF)细胞因子具有多种重要生物学功能,并与某些癌症和自身免疫性疾病相关。
Trimer-Tag?是全球一个利用人源三聚体化标签设计及开发共价连接的重组三聚体融合蛋白(三聚体标签蛋白)的技术平台。由Trimer-Tag?开发的三聚体化蛋白对三聚体依赖性疾病靶点具有很强的有效性及良好的安全性。
公司应用Trimer-Tag?(蛋白质三聚体化)技术平台,并凭借自有的生物制药生产能力,搭建研发管线。
扫码下载APP,找工作更方便